Survival rates of prostate cancer

Survival rates are estimated and used as a way of explaining to cancer patients what their prognosis is. Survival statistics can help a patient understand how long they may survive after they are diagnosed with cancer.

While this may give hope to some patients, others may find survival estimates unhelpful and may not even want to hear them.

When dealing with cancer patients, the 5-year survival rate is often used, which refers to the proportion of people who survive for at least five years after they have been diagnosed with cancer. Many patients who are diagnosed may survive more than five years or may even be cured with treatment.

Five-year relative survival rates adjust for the fact that people may die from causes unrelated to cancer and are relative to the expected survival rates of people without cancer. Survival rates are often based on outcome data for large numbers of people who were diagnosed with cancer and cannot be used to predict the prognosis for a specific individual.

Prostate cancer is a relatively slow growing cancer in most individuals and therefore survival rates are usually high. Doctors explain to the patients how well the numbers may apply to them in the context of the various aspects of their disease. According to the most recent survival data on all stages of prostate cancer:

  • The relative 5-year survival rate is between 99% and 100%
  • The 10-year survival rate is 98%
  • The 15-year survival rate is 93%

Survival by stage

Survival rates also vary depending on the stage of the cancer when it was first diagnosed. Patients with cancers that have been detected in the early stages have a longer survival rate compared with those with cancers detected at a later and more advanced stage.

A database held by the National Cancer Institute provides survival data for different types of cancer that are categorised according to whether they were local, regional or distant at the time of diagnosis. Local refers to cancer confined to the prostate, regional to cancer that has spread to nearby but not distant areas, and distant refers to cancer that has spread to distant lymph nodes, bones or other areas of the body. According to the cancer stage at diagnosis, the 5-year survival rates are:

  • 100% for local stage
  • 100% for regional stage
  • 28% for distant stage

Further Reading

Last Updated: Jan 2, 2023

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2023, January 02). Survival rates of prostate cancer. News-Medical. Retrieved on December 22, 2024 from https://www.news-medical.net/health/Survival-rates-of-prostate-cancer.aspx.

  • MLA

    Mandal, Ananya. "Survival rates of prostate cancer". News-Medical. 22 December 2024. <https://www.news-medical.net/health/Survival-rates-of-prostate-cancer.aspx>.

  • Chicago

    Mandal, Ananya. "Survival rates of prostate cancer". News-Medical. https://www.news-medical.net/health/Survival-rates-of-prostate-cancer.aspx. (accessed December 22, 2024).

  • Harvard

    Mandal, Ananya. 2023. Survival rates of prostate cancer. News-Medical, viewed 22 December 2024, https://www.news-medical.net/health/Survival-rates-of-prostate-cancer.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
AI tool enhances cancer diagnosis by transforming standard tissue images